Table 3

Outcome measure data: outcome data for completed (fully or partially) measures have been presented

 Fast trackWaiting listEffect size (95% CI) at 4 weeks
Baseline (mean (SD) or n (%)4 weeks (mean (SD) or n (%)Change score
Mean (SD)
8 week (mean (SD) or n (%)Baseline (mean (SD) or n (%)4 weeks (mean (SD) or n (%)Change score
Mean (SD)
8 week (mean (SD) or n (%)
Primary end pointN=26N=23N=27N=24
POS16.8 (5.6)11.2 (7.9)−5.7 (7.5)17.0 (6.3)16.8 (8.9)−0.4 (8.0)−0.7 (−1.2 to −0.1)
The mean change difference between the two arms was −5.3 (95% CI: −9.8 to −0.7) Independent t test p=0.02
Secondary outcomes
 Patients 
 POSN=19N=15
11.2 (7.3)12.5 (6.6)
 D12N=25*N=22*N=19N=27N=24N=15
22.8 (8.7)21.6 (10.1)−0.8 (7.2)20.4 (9.8)25.9 (8.2)25.0 (10.7)−0.6 (21.3)21.3 (10.5)−0.3 (−0.9 to 0.3)
 KBILD†N=26N=23N=19N=27N=24N=15
35.8 (13.0)40.0 (16.2)3.5 (11.0)43.2 (18.4)32.3 (12.9)30.3 (16.2)−2.6 (21.3)34.9 (18.0)0.6 (0.0 to 1.2)
 SGRQN=25‡N=22‡N=18‡N=26§N=24N=15
 Symptoms62.2 (17.7)62.0 (20.5)1.4 (16.5)52 (20.1)66.3 (24.5)65.8 (23.0)−2.0 (23.7)60.2 (23.8)−0.2 (−0.8 to 0.4)
 Activity88.9 (9.7)85.3 (17.6)−3.1 (13.6)87.1 (10.7)93.7 (5.0)92.4 (7.8)−1.6 (6.8)91.4 (5.2)−0.5 (−1.1 to 0.1)
 Impact61.6 (18.0)56.3 (20.3)−4.0 (19.7)57.4 (20.8)71.4 (12.8)74.8 (14.9)2.8 (13.3)62.3 (13.5)−1.0 (−1.6 to −0.4)
 Total70.0 (13.0)66.0 (16.4)−2.8(14.9)65.7 (14.7)76.8 (10.1)78.6 (11.8)0.7 (10.5)70.8 (10.8)−0.9 (−1.5 to −0.3)
 MRCN=26N=23N=19N=27N=24N=15
 Median444554
 IQR (25–75)4–54–54–54–54–54–5
 HADsN=26N=23N=19N=27N=24N=15
 Anxiety9.6 (4.6)8.1 (4.1)−1.7 (3.3)7.1 (4.6)9.7 (5.7)10.8 (5.5)1.2 (4.8)7.9 (5.5)−0.6 (−1.1 to 0.0)
 Depression9.0 (3.1)9.4 (3.0)0.3 (3.2)8.3 (3.7)11.0 (4.7)12.3 (4.8)1.5 (4.12)9.3 (4.5)−0.7 (−1.3 to −0.1)
 Total score18.6 (6.4)17.5 (6.3)−1.4 (5.0)15.4 (7.7)20.7 (9.0)23.0 (9.7)2.8 (8.1)17.2 (9.4)−0.7 (−1.2 to −0.1)
Carers
 POSN=19N=15N=13N=26N=22N=15
17.8 (6.5)14.7 (6.5)−2.9 (5.8)16.1 (6.9)18.5 (6.2)18.0 (8.4)−0.7 (9.6)13.7 (6.3)−0.4 (−1.1 to 0.2)
 ZBIN=19N=16N=13N=26N=23N=16
22.2 (15.2)22.3 (15.3)0.1 (0.2)26.2 (13.4)32.2 (11.7)31.7 (17.3)−0.1(0.3)25.4 (13.4)−0.6 (−1.2 to 0.1)
 HADsN=19N=16N=13N=26N=23N=16
 Anxiety9.3 (4.3)8.8 (4.8)−0.5 (4.8)9.2 (3.7)11.0 (5.9)11.7 (5.6)0.6 (5.3)9.8 (4.6)−0.6 (−1.2 to 0.1)
 Depression7.0 (4.9)6.4 (4.1)−0.3 (3.5)7.0 (4.2)8.7 (5.0)9.6 (4.9)1.0 (4.6)7.2 (3.9)−0.7 (−1.3 to 0.0)
 Total score16.3 (8.7)15.2 (8.3)−0.8 (8.0)16.2 (7.4)19.7 (10.4)21.3 (9.9)1.7 (8.7)17.0 (8.2)−0.7 (−1.3 to 0.0)
 CQLC†N=18N=15N=13N=25N=21N=13
 Burden21.9 (8.3)21.5 (7.1)−0.6 (6.9)20.2 (5.7)25.2 (8.3)25.2 (8.5)−0.2 (8.0)22.1 (9.2)−0.5 (−1.1 to 0.2)
 Disruptiveness7.8 (6.0)7.1 (6.9)−0.6 (4.3)7.7 (4.8)9.6 (5.4)9.3 (5.5)0.0 (4.9)7.6 (5.9)−0.4 (−1.0 to 0.3)
 Adaptation15.6 (5.1)15.8 (6.1)0.5 (4.3)15.9 (5.4)14.7 (6.8)14.4 (5.7)0.1 (5.3)16.8 (4.2)0.2 (−0.4 to 0.9)
 Financial2.8 (3.0)2.5 (3.0)−0.4 (2.1)2.4 (3.6)2.7 (2.9)2.7 (2.8)0.3 (2.5)2.3 (2.1)−0.1 (−0.7 to 0.6)
 Total score60.8 (17.4)58.5 (15.3)−2.5 (11.0)58.3 (15.6)66.7 (16.3)66.3 (18.4)0.7 (15.2)60.2 (23.9)−0.4 (−1.1 to 0.2)
  • All analyses conducted by originally assigned groups.

  • Lower scores on the SGRQ and higher scores on the KBILD indicate a better quality of life.

  • *One patient had >three items missing on the D12 questionnaire and was therefore excluded as per author's instructions.

  • †Increase in scores indicates improvement.

  • ‡One patient completed McGill quality of life not SGRQ.

  • §One patient removed as >six items missing on activity SGRQ.

  • CQLC, carer quality of life cancer; HADs, Hospital Anxiety and Depression Scale; KBILD, King's Brief Interstitial Lung Disease questionnaire; MRC, Medical Research Council Scale; POS, Palliative Care Outcome Scale; SGRQ, St George's Respiratory Questionnaire; ZBI, Zarit Burden Inventory.